Hurtado, Maria D. http://orcid.org/0000-0002-2322-7334
Cifuentes, Lizeth http://orcid.org/0000-0001-7865-2947
Campos, Alejandro http://orcid.org/0000-0002-6294-8652
De La Rosa, Alan
Kapoor, Ekta
Faubion, Stephanie S.
Hensrud, Donald D.
Camilleri, Michael http://orcid.org/0000-0001-6472-7514
Acosta, Andres http://orcid.org/0000-0003-2286-489X
Article History
Received: 23 November 2021
Revised: 23 August 2022
Accepted: 3 October 2022
First Online: 13 October 2022
Competing interests
: Dr. Acosta is a stockholder in Gila Therapeutics, Phenomix Sciences; he serves as a consultant for Rhythm Pharmaceuticals, General Mills. Dr. Camilleri is a stockholder in Phenomix Sciences and Enterin and serves as a consultant to Takeda, Allergan, Rhythm, Kallyope, and Arena with compensation to his employer, Mayo Clinic. Dr. Kapoor serves as a consultant for Mithra and Astellas Pharmaceuticals. She is also a consultant for the company Womaness. The rest of the authors have nothing to disclose.